OPR - Delayed Quote • USD EXAI May 2024 17.500 call (EXAI240517C00017500) Follow 0.0500 0.0000 (0.00%) As of March 25 at 10:13 AM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for EXAI240517C00017500 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: EXAI Exscientia Business and Financial Update for the Full Year 2023 Exscientia plc's (NASDAQ:EXAI) market cap touched US$797m last week, benefiting both individual investors who own 48% as well as institutions Exscientia to Report Full Year 2023 Financial Results on March 21, 2024 The Top 3 Healthcare Stocks to Buy on Weakness in 2024 Exscientia to Present at Upcoming Investor Conferences in March Oxford drug company sacks chief executive over ‘inappropriate’ relationships with staff Exscientia fires CEO after probe over relationship with two employees Exscientia Initiates Clinical Study to Further Evaluate Functional Precision Medicine Platform in Cancer Patients The Cutting Edge: 3 Stocks to Buy for the Next Generation of Biotech Breakthroughs M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024 Professor Andrew L. Hopkins appointed Commander of the Order of the British Empire (CBE) Ozempic drugmaker to open AI research hub in King’s Cross
